Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus

European Journal of Human Genetics

Volumn 12, Issue 8, 2004, Pages 620-626

  Barreto, Marta ^a   Santos, Eugénia ^b   Ferreira, Ricardo ^a   Fesel, Constantin ^a   Fontes, Maria Francisca ^a   Pereira, Clara ^c   Martins, Berta ^c   Andreia, Rita ^b   Viana, João Faro ^b   Crespo, Francisco ^b   Vasconcelos, Carlos ^b   Ferreira, Carlos ^b   Vicente, Astrid Moura ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b Associacção Dos Doentes Com Lupus   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

CTLA4; Functional polymorphism; Genetic susceptibility; Meta analysis; Systemic lupus erythematosus

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; DINUCLEOTIDE REPEATS; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; RESTRICTION MAPPING;

EID: 4444354041     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201214     Document Type: Article

References (30)

1. Kotzin B: Systemic lupus erythematosus. Cell 1996; 85: 303-306.
2. Lindqvist AK, Alarcon-Riquelme M: The genetics of systemic lupus erythematosus. Scand J Immunol 1999; 50: 562-571.
3. Gaffney P, Kearns G, Shark K et al: A genome-wide search for susceptibility genes in systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998; 95: 14875-14879.
4. Moser K, Neas B, Salmon J et al: Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869-14874.
5. Oosterwegel M, Greenwald R, Mandelbrot D, Lorsbach R, Sharpe A: CTLA-4 and T cell activation. Curr Opin Immunol 1999; 11: 294-300.
6. Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
7. Takahashi T, Tagami T, Yamazaki S et al: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303-310.
8. Kristiansen OP, Larsen ZM, Pociot F: CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 2000; 1: 170-184.
9. Heward J, Gordon C, Allahabadia A, Barnett AH, Franklyn JA, Gough SC: The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis 1999; 58: 193-195.
10. Hudson LL, Rocca K, Song YW, Pandey JP: CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 2002; 111: 452-455.
11. Liu MF, Wang CR, Lin LC, Wu CR: CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 2001; 10: 647-649.
12. Matsushita M, Tsuchiya N, Shiota M et al: Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 1999; 54: 578-584.
13. Ahmed S, Ihara K, Kanemitsu S et al: Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford) 2001; 40: 662-667.
14. Lee YH, Kim YR, Ji JD, Sohn J, Song GG: Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus. Lupus 2001; 10: 601-605.
15. Pullmann Jr R, Lukak J, Skerenova M et al: Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1999; 17: 725-729.
16. Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C: A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4. J. Biol Chem 2002; 277: 46478-46486.
17. Mäurer M, Loserth S, Kolb- Mäurer A et al: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T cell activation. Immunogenetics 2002; 54: 1-8.
18. Conne B, Stutz A, Vassali J: The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med 2000; 6: 637-641.
19. Kuersten S, Goodwin E: The power of the 3′ UTR: translational control and development. Nat Rev Genet 2003; 4: 626-637.
20. Lowe RM, Graham J, Sund G et al: The length of the CTLA-4 microsatellite (AT)n-repeat affects the risk for type 1 diabetes. Diabetes Incidence in Sweden Study Group. Autoimmunity 2000; 32: 173-180.
21. Gu C, Province MA, Rao DC: Genetic dissection of complex traits; in Rao DC, Province MA (eds): Advances in genetics. Academic Press: San Diego; 2001, vol 42: pp 255-272.
22. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
23. Mantel N, Haenszel: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
24. Stephens M, Donnely P: A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
25. Abecasis GR, Cookson WO: GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182-183.
26. Eagar T, Karandikar N, Bluestone J, Miller S: The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol 2002; 32: 972-981.
27. Perez V, Parijs L, Biuckians A, Zheng X, Strom T, Abbbas A: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997; 6: 411-417.
28. Ueda H, Howson J, Esposito L et al: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
29. Oaks MK, Hallett KM: Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 2000; 164: 5015-5018.
30. Liu MF, Wang CR, Chen PC, Fung LL: Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scand J Immunol 2003; 57: 568-572.